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Summary
Dry eye is an allegedly autoimmune disorder for which the initiating
mechanisms and the targeted antigens in the ocular surface are not known,
yet there is extensive evidence that a localized T helper type 1 (Th1)/Th17
effector T cell response is responsible for its pathogenesis. In this work, we
explore the reconciling hypothesis that desiccating stress, which is usually
considered an exacerbating factor, could actually be sufficient to skew the
ocular surface’s mucosal response to any antigen and therefore drive the
disease. Using a mouse model of dry eye, we found that desiccating stress
causes a nuclear factor kappa B (NF-jB)- and time-dependent disruption of
the ocular surface’s immune tolerance to exogenous ovalbumin. This
pathogenic event is mediated by increased Th1 and Th17 T cells and
reduced regulatory T cells in the draining lymph nodes. Conversely, topical
NF-jB inhibitors reduced corneal epithelial damage and interleukin (IL)-1b
and IL-6 levels in the ocular surface of mice under desiccating stress. The
observed effect was mediated by an augmented regulatory T cell response, a
finding that highlights the role of mucosal tolerance disruption in dry eye
pathogenesis. Remarkably, the NF-jB pathway is also involved in mucosal
tolerance disruption in other ocular surface disorders. Together, these
results suggest that targeting of mucosal NF-jB activation could have
therapeutic potential in dry eye.
Keywords: conjunctival tolerance, desiccating stress, dry eye, mucosal toler-
ance, ocular surface
Introduction
Dry eye disease (DED), a highly prevalent disorder, is char-
acterized by a dysfunctional tear film and ocular surface
[1]. Although it was initially ascribed a minor role, inflam-
mation is now considered to be the main underlying mech-
anism in the pathophysiology of DED and is the target of
most current treatment options [2]. Hallmarks of mucosal
inflammation are commonly observed in DED, such as
increased proinflammatory cytokine levels in the tear film
[3,4], epithelial apoptosis [5] and leucocyte infiltration [6].
In addition, a key role of the adaptive immune response in
DED is supported by the clinical impact of cyclosporin A
treatment [7] and the fact that adoptive transfer of CD41
T cells reproduces the mucosal disease [8].
The conjunctiva, as any other highly exposed mucosal
surface, is challenged continuously by environmental fac-
tors and is loaded with both exogenous and endogenous
antigens, yet it remains uninflamed and thus fully func-
tional in most individuals. The regulatory mechanisms
behind this protective stance ultimately derive from muco-
sal tolerance [9–11]; that is, the suppression of a potentially
harmful adaptive immune response against innocuous
antigens. A recent hypothesis put forth that DED is a local-
ized form of mucosal autoimmune disease, triggered when
the ocular surface’s immune balance is overthrown by still
uncharacterized factors, perhaps challenging environmen-
tal conditions [12]. Supporting this hypothesis, desiccating
stress (DS) is sufficient to induce pathogenic T helper type
1 (Th1) [5] and Th17 [13] T cell responses in a widely
studied mouse model of DED [8]. It remains to be deter-
mined whether the T cells involved are specific for some
as-yet undefined autoantigens, or if they actually represent
the generalized disruption of the protective tolerance
mechanisms to any mucosal antigen.
Regarding its potential role in DED pathogenesis, muco-
sal tolerance is known to be affected in another ocular
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surface disorder, eye drop preservative toxicity [10] and,
more importantly, that restoration of this immune func-
tion can protect mice from the disease [11]. Mucosal toler-
ance is governed by the epithelial lining, which exerts a
tolerogenic or immunogenic sway at the initiation of
adaptive immune responses [14]. In this process, epithelial
nuclear factor kappa B (NF-jB) pathway signalling plays a
decisive role in the downstream immune outcome
[11,14–16], thus affording an opportunity to control the
mucosal epithelium’s influence by pharmacological inhibi-
tion. In the ocular surface, the epithelial NF-jB pathway
acts as a central regulator of inflammation in several cor-
neal and conjunctival disorders [17]. For this work, we fav-
oured the possibility that DS initiates DED by triggering a
generalized disruption of ocular surface immune tolerance,
instead of a specific autoimmune response towards corneal
and conjunctival antigens. Therefore, we set out to assess
whether mucosal tolerance is indeed affected in a DS-
induced murine model of DED and if it is involved in dis-
ease development.
Materials and methods
Mice. BALB/c and C3H mice (8–12 weeks old), which were
bred and maintained in our conventional animal facility,
were used for the in-vivo experiments. All experiments
were approved by the Institute of Experimental Medicine
Animal Ethics Committee and adhered to the Association
for Research in Vision Ophthalmology Statement for the
Use of Animals in Ophthalmic and Vision Research.
Reagents and antibodies. All reagents were from Sigma-
Aldrich (Buenos Aires, Argentina) unless specified other-
wise. Fluorochrome-tagged antibodies were from BioLe-
gend (San Diego, CA, USA) and ImmunoTools (Friesoythe,
Germany). Grade V ovalbumin (OVA) was used in all
experiments.
DS model. Mice were subjected to DS by subcutaneous
(s.c.) injection of 05 mg scopolamine hydrobromide
(Boehringer Ingelheim, Buenos Aires, Argentina) three
times a day (9 a.m., 1 p.m. and 5 p.m.), and by housing in
a perforated cage to allow forced air to flow from a fan for
12 h a day (9 a.m.29 p.m.). For some experiments, either 5
ml/eye of phosphate-buffered saline, 01 mM pyrrolidine
dithiocarbamate (PDTC) or 05 mM sulphasalazine (SSZ)
were instilled on both eyes every time the mice were
injected.
OVA instillation and immunization for delayed-type hyper-
sensitivity (DTH) assays. Mice under DS were instilled on
both eyes, once or twice per day at the indicated time-
points with 5 ml/eye of 2 mg/ml OVA. Immunization and
DTH assays were performed as described previously [11] at
the time-points indicated.
Assessment of tear production and of corneal surface dam-
age and irregularity. Tear production was measured by wet-
ting of phenol-red impregnated filter paper, and corneal
surface damage was assessed by fluorescein uptake and
graded by the National Eye Institute scoring system, as
described elsewhere [18,19].
Eye explants and cells from eye-draining lymph nodes. After
After euthanasia, the entire eye globe with the tarsal
conjunctiva still attached was excised under aseptic con-
ditions with the aid of a dissection microscope, as
described elsewhere [10]. Both explants from each ani-
mal were pooled, washed three times with phosphate-
buffered saline (PBS) and then cultured in 1 ml of
medium without serum. Supernatants were collected
after 24 h for further analysis. For analysis of eye-
draining lymph node cells, submandibular lymph nodes
were excised and rendered into a cell suspension by
mechanical dissociation and sieving through wire mesh.
For some experiments, inguinal lymph nodes were also
collected as controls. For functional experiments, CD31
T cells were isolated by negative selection with magnetic
beads (Miltenyi Biotec, Bergisch Gladbach, Germany).
Purity [assessed by fluorescence activated cell sorter
(FACS)] was > 95% for all experiments.
Cell lines and cultures. Cell cultures were performed in
RPMI-1640 medium supplemented with 10% fetal calf
serum, 10 mM glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin and 5 3 1025 M 2-mercaptoethanol in a
humidified incubator with 5% CO2 at 378C.
Enzyme-linked immunosorbent assay (ELISA). Interleukin
(IL)-1b and IL-6 concentrations in supernatants were
determined with commercial ELISA kits according to the
manufacturer’s instructions (BD Biosciences, Buenos Aires,
Argentina).
Local adoptive transfer (LAT) assays. T cells from the sub-
mandibular lymph nodes of mice under DS were mixed
with T cells from OVA-immunized mice and OVA-
pulsed antigen-presenting cells (T cell-depleted spleno-
cytes from naive mice) at a 1 : 1 : 1 ratio, and 35 ml of
the resulting cell suspension containing a total of
3 3 106 cells were injected into the footpads of naive
mice. Footpad thickness was recorded before and 24 h
after cell injection by a masked observer, and swelling
calculated accordingly.
In-vitro expansion of OVA-specific T cells. T cells from
the submandibular lymph nodes of mice under DS were
cultured for 7 days at a density of 5 3 106 cells/ml in the
presence of an equal number of mitomycin-treated, T cell-
depleted splenocytes as a source of antigen-presenting cells
and 100 mg/ml OVA. After Ficoll gradient centrifugation to
remove dead cells (> 60% at the end of the culture period),
cells were stimulated and processed as indicated for intra-
cellular cytokine staining.
Mucosal tolerance disruption in dry eye
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Immunostaining and flow cytometry. For antigen staining,
cells were washed in PBS with 05% bovine serum albumin,
incubated for 15 min with 5 mg/ml 24G2 antibody (puri-
fied from ascites fluid) to block non-specific binding to Fc
receptors and then labelled with fluorochrome-conjugated
antibodies at previously titrated concentrations for 30 min
at 48C. Forkhead box protein 3 (FoxP3) staining was per-
formed as indicated by the manufacturer (BioLegend). For
intracellular cytokine staining, cells were first stimulated for
5 h with 50 ng/ml phorbol myristate acetate (PMA) and 1
mg/ml ionomycin in the presence of 10 mg/ml brefeldin A,
then washed, fixed in 1% paraformaldehyde, permeabilized in
01% saponin and finally stained with the corresponding anti-
bodies. For flow cytometry analysis, cells were washed thor-
oughly in PBS with 1 mM ethylenediamine tetraacetic acid
before acquisition on a FACScalibur cytometer (Becton Dick-
inson, Buenos Aires, Argentina). Data were analysed with
Flowing Software (Perttu Terho, Center for Biotechnology,
Turku, Finland; www.flowingsoftware.com). Optimal com-
pensation and gain settings, as well as viable cell gating, were
determined as described previously [20]. Overlaid histogram
graphs are plotted in normalized form as a percentage of max-
imum for each histogram.
T cell proliferation assays. Single cell suspensions were
labelled with carboxyfluorescein succinimidyl ester (CFSE),
according to the manufacturer’s instructions (BioLegend).
For antigen proliferation assays, 2 3 105 cells were cultured
for 3 days in 96-well plates containing 100 mg/ml OVA.
Soluble anti-CD3 antibody was added to some cultures at
the concentrations indicated.
Adoptive transfer. CD31 T cells were isolated from the sub-
mandibular lymph nodes of mice treated as indicated in
the text and pooled (each mouse yielding approximately
15 3 106 cells). Cells were then transferred to recipient
mice by intraperitoneal injection of 15 3 106 cells/05 ml
of phosphate-buffered saline.
Statistical analysis. Student’s t-test and analysis of variance
(ANOVA) with Dunnett’s post-hoc test were used to compare
means of two and three or more samples, respectively. Sig-
nificance was set at P < 005 (two-tailed tests) and calcula-
tions were performed using GraphPad Prism version 5
software (GraphPad Software, La Jolla, CA, USA).
Results
DS disrupts ocular mucosal tolerance in a NF-jB-
dependent fashion
We initially explored the effect of DS on the ocular surface’s
immune homeostasis by employing a widely characterized
murine model of DED [8]. To this aim, mice were sub-
jected to DS for 5 days by combining simultaneous daily
injections of scopolamine to reduce tear secretion and
exposure to a controlled air draft to increase tear evapora-
tion. In this model, a pathogenic T cell response against
corneal and conjunctival antigens ensues rapidly, which
can sustain ocular surface damage after cessation of DS
[8,13,21]. For the first part of this work, as the antigens
involved in DED’s adaptive immune response are not
known, we included ocular instillation of ovalbumin
(OVA) at different time-points to assess the antigen-
specific conjunctival immune response to a well-
characterized antigen [9–11] (Fig. 1a). As expected, we
found that in non-DS mice, ocular instillation of OVA
markedly reduced in-vitro antigen-specific T cell prolifera-
tion and the in-vivo DTH response after s.c. immunization
with OVA in adjuvant (Fig. 1b,c). This phenomenon is
referred to commonly as mucosal tolerance, and involves
the induction of antigen-specific regulatory T cells (Tregs)
that suppress subsequent inflammation [9,10]. Interest-
ingly, when OVA was administered from day 1 of DS, mice
also developed comparably blunted DTH and T cell
responses, suggesting that mucosal tolerance was not
affected early by DS. However, when OVA instillation was
delayed until day 4, only non-DS mice developed sup-
pressed DTH responses, whereas DS mice showed full
DTH responses to antigen. As we have shown previously in
another murine model of eye disease [11], ocular surface
immune tolerance is dependent upon NF-jB activation in
conjunctival epithelial cells. Therefore, we tested whether
topical NF-jB inhibitors pyrrolidine dithiocarbamate
(PDTC) and SSZ were able to prevent the disruption of
immune homeostasis by DS. As depicted in Fig. 1c, topical
instillation of either of the two inhibitors restored mucosal
tolerance to OVA administered on days 4 and 5 to DS
mice. NF-jB inhibitors in and of themselves had little
effect on conjunctival tolerance to OVA in non-DS mice, as
we have shown previously [11]. To account for strain-
specific differences in the immune response, the experi-
ments described above were performed separately in both
BALB/c (Fig. 1) and C3H mice (data not shown), and as
the results were comparable, all subsequent experiments
were carried out with BALB/c mice. Together, these results
show that DS induces a time-dependent disruption of
mucosal tolerance in mice, an event that is mediated by
NF-jB activation in the ocular surface.
DS modifies the type of antigen-specific T cells
induced at the ocular mucosal surface
Once we had established that DS leads to a time-dependent
breakdown of ocular mucosal tolerance, we studied the
antigen-specific T cell response directly in the eye-draining
lymph nodes. To allow for appropriate comparisons, the
experimental design was modified slightly to include either
early (days 1–3, d1–3) or delayed OVA instillation (days 4–
6, d4–6) relative to DS (Fig. 2a). As mucosal tolerance else-
where relies upon antigen-specific Tregs, we first tested if
M. Guzman et al.
250 VC 2016 British Society for Immunology, Clinical and Experimental Immunology, 184: 248–256
such cells were actually being induced in the eye-draining
lymph nodes of mice that received early or delayed OVA.
Given the low frequency of antigen-specific T cells in wild-
type mice, we resorted to the LAT assay due to its high sen-
sitivity [22]. For this experiment, T cells from the eye-
draining lymph nodes of DS, DS 1 OVA d1–3, and
DS 1 OVA d4–6 mice were mixed with effector T cells
from OVA-immunized mice and OVA-pulsed antigen-pre-
senting cells, and then injected into the footpads of naive
mice. As shown in Fig. 2b, T cells from DS 1 OVA d1–3
mice suppressed the antigen-specific DTH response signifi-
cantly, whereas T cells from DS 1 OVA d4–6 mice had no
effect compared to antigen-naive DS mice. These findings
confirmed that antigen-specific Tregs were expanded in
donor mice when OVA was administered on the first 3 days
of DS, but not when administered later. Conversely, disrup-
tion of mucosal tolerance should implicate the induction
of antigen-specific effector T cells, and DS has been shown
to favour Th1 and Th17 responses [5,13]. Therefore, we
also tested for OVA-specific interferon (IFN)-g- and IL-17-
secreting T cells in the eye-draining lymph nodes, and to
overcome the low frequency of such cells we first expanded
the rare antigen-specific T cells in vitro. As depicted in Fig.
2c, after one round of OVA-specific expansion both IFN-
g1 and IL-171 CD41 cells were increased significantly in
the lymph node cultures of DS 1 VA d4–6 mice but not in
DS 1 OVA d1–3 mice compared to antigen-naive mice.
This shows that antigen-specific effector T cells were fav-
oured after 3 days of DS, but not before. Moreover, the lack
of expansion in DS 1 OVA d1–3 mice despite antigenic
exposure is consistent with the detection of OVA-specific
Tregs by the LAT assay. These results show that DS induces a
time-dependent change in the antigen-specific T cells
induced at the ocular mucosal surface: from the basal-state
Treg-controlled response to another dominated by the
expansion of IFN-g- and IL-17-producing effector T cells.
Prevention of mucosal tolerance disruption at the
ocular surface ameliorates DED
Mice under DS have markedly reduced tear secretion due
to the effect of muscarinic blockade by scopolamine (for
the first 5 days), but then fail to recover tear production
rapidly because a CD41 T cell-dependent immune
response develops against the cornea, conjunctiva and
lacrimal glands [8,21]. We hypothesized that, if disrup-
tion of ocular surface immune tolerance was indeed a
pathogenic event in DED and not a mere epiphenome-
non of local inflammation, its prevention by NF-jB
inhibitor PDTC during DS should slow disease develop-
ment. We assessed DED in mice by measuring corneal
epithelial damage, tear production and proinflammatory
cytokine secretion (IL-1b and IL-6), three parameters in
clinical use [4]. As shown in Fig. 3a, DS 1 inhibitor
mice had lower fluorescein staining scores than DS mice
on day 5, evidencing less corneal epithelial damage and
DED severity [19]. As expected, due to the muscarinic
blockade, both DS and DS 1 inhibitor mice had reduced
tear secretion during DS induction (Fig. 3b). Of note,
during this period DS 1 inhibitor mice exhibited slightly
less tear secretion than DS 1 mice, which could be
ascribed to the lower extent of corneal damage and the
associated reflex tear production in the former group. By
Fig. 1. Desiccating stress (DS) disrupts ocular mucosal tolerance in a nuclear factor kappa B (NF-jB)-dependent fashion. (a) Experimental
design for assessing the effect of DS on ocular surface immune tolerance. Mice subjected to normal environmental conditions or DS for 5 days
were instilled ovalbumin (OVA) daily in both eyes from days 1 to 5 (d1–5) or on days 4 and 5 only (d4–5), then immunized (imm)
subcutaneously (s.c.) with OVA 1 complete Freund’s adjuvant (CFA) and assayed 1 week later. (b) In-vitro T cell proliferation of splenocytes
harvested on day 15 and stimulated with OVA over a 4-day culture period, as assayed by carboxyfluorescein succinimidyl ester (CFSE) dilution.
Results are expressed relative to the proliferative fraction observed in non-instilled, OVA-immunized mice. (c) In-vivo delayed-type hypersensitivity (DTH)
assay (OVA-induced footpad swelling) measured 48 h after challenge. For this experiment, NF-jB inhibitors (inh d1–5) pyrrolidine dithiocarbamate
(PDTC) (P) or sulphasalazine (S) were instilled daily from days 1 to 5 during DS induction, and OVA was instilled daily only on days 4 and 5. Results are
shown as the difference between the antigen-injected and phosphate-buffered saline (PBS)-injected footpads. Data are expressed as mean6 standard error
of the mean (s.e.m.) (n5 3–5 experiments, 3–5 mice/group, BALB/c mice). *Indicates a statistically significant difference with the control group
(immunized only), as determined by analysis of variance (ANOVA) and Dunnett’s post-hoc test.
Mucosal tolerance disruption in dry eye
VC 2016 British Society for Immunology, Clinical and Experimental Immunology, 184: 248–256 251
contrast, DS 1 inhibitor mice recovered to baseline lev-
els, on average, 3–4 days before DS mice. Compared with
DS mice, tear production was increased significantly in
DS 1 inhibitor mice after cessation of DS for up to 10
days. Regarding cytokine levels at the ocular surface, eye
explants obtained on day 5 from DS mice produced
higher IL-1b and IL-6 concentrations, which are also
observed in DED patients [4] (Fig. 3c). By contrast, com-
parable explants from DS 1 inhibitor mice released near-
control levels of these proinflammatory cytokines. In
other words, reduced corneal damage and inflammatory
markers were observed in DS 1 inhibitor mice at a time-
point (day 5) in the disease model when there was almost
no difference in tear levels and DS was constant, suggest-
ing that a pathogenic host response was being modified
by NF-jB inhibition.
Prevention of mucosal tolerance disruption at the
ocular surface blunts the development of a
proinflammatory T cell response in the lymph nodes
As DED is mediated by an autoimmune T cell response
[8], we examined the eye-draining lymph nodes to deter-
mine if topical NF-jB inhibitor PDTC was indeed affecting
the T cell compartment. Day 5 of DS was selected as a
representative time-point because, as shown previously,
environmental stress and tear production were comparable
between DS and DS 1 inhibitor treatments. It should be
noted that these experiments did not include OVA instilla-
tion because they were intended to examine the overall T
cell response, including those T lymphocytes specific for
ocular surface antigens. We observed no difference in the
total number of CD31 and CD31CD41 cells between con-
trol, DS and DS 1 inhibitor mice (data not shown). Never-
theless, T cells from DS mice proliferated more upon anti-
CD3 stimulation than those from control and
DS 1 inhibitor mice (Fig. 4a), which could be interpreted
as decreased regulatory T cell activity [23]. In line with this
finding, we detected in DS mice, but not in DS 1 inhibitor
mice, higher numbers of activated CD41 T cells (CD691
and CD251) and memory CD41 T cells (CD62Llo
CD44hi), and lower numbers of CD41 FoxP31 T cells than
in control mice (Fig. 4b). These phenotypical differences
are indeed suggestive of reduced number and activity of
regulatory T cells in DS mice, as described previously [23],
which in turn favour pathogenic Th1 and Th17 cell expan-
sion [5,23–25]. Consistently, we detected increased IFN-g
and IL-17A production by CD41 T cells in DS mice, but
not in DS 1 inhibitor mice.
Lending further credit to the observed phenotypical and
functional differences in the T cell response, we detected a
significantly higher number of donor T cells in the cervical
lymph nodes (and also in inguinal lymph nodes) of mice
that were transferred adoptively with cervical lymph node
cells from DS animals (Fig. 4c) and then subjected to DS
themselves. Cagemates that were transferred adoptively
with cells from DS 1 inhibitor mice showed less donor T
cell homing to lymph nodes, being not significantly
Fig. 2. Effector T cells are favoured instead of regulatory T cells
(Tregs) after 3 days of desiccating stress (DS). (a) Experimental design
for assessing the effect of DS on the T cell response specific for an
ocular surface antigen. Mice subjected to DS were instilled ovalbumin
(OVA) daily in both eyes from days 1 to 3 (d1–3) or from days 4 to 6
(d4–6), and their T cells were isolated on day 7. (b) Local adoptive
transfer assay for antigen-specific suppression. T cells from the
submandibular lymph nodes of either antigen-naive mice (Ct),
ovalbumin (OVA) d1–3 or OVA d4–6 mice were isolated and mixed
with T cells from OVA 1 complete Freund’s adjuvant (CFA)-
immunized mice and OVA-pulsed antigen-presenting cells, then
injected into the footpads of naive mice. Swelling was measured 24 h
later and expressed as the difference from preinjection footpad
thickness. (c) Representative dot plots (top) and bar graphs (bottom)
of cytokine production as assayed by intracellular flow cytometry in
OVA-expanded CD41 T cells from Ct, OVA d1–3 and OVA d4–6
mice. Data are expressed as mean 6 standard error of the mean
(s.e.m.) (n 5 3 experiments, 3 mice/group, BALB/c mice); *n.s.
indicates a statistically significant or non-significant difference,
respectively, between the marked groups or with the control group, as
determined by analysis of variance (ANOVA) and Sidak’s post-hoc test.
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different from those that received cells from control mice
(Fig. 4c). The same tendency was observed when donor
CD41 and CD81 T cell migration was analysed separately
(data not shown). These findings are consistent with mem-
ory T cell migration and in line with the increase in effector
and effector memory T cells reported in the eye-draining
lymph nodes of DS mice [13].
Discussion
The conception of DED as the end result of an auto-
immune response that is initiated by challenging environ-
mental conditions and directed towards the ocular surface
[12] poses intriguing questions, and at the same time opens
new avenues for therapeutic intervention. Regarding the
experimental proof, the implications of this hypothesis are
twofold: on one hand, that there are protective mechanisms
in place at the ocular surface under normal circumstances,
and on the other hand that these processes are over-run by
a harsh environment and allow for an autoimmune
response to ensue. Supporting the first claim, we have
reported previously that under physiological conditions,
the conjunctiva drives the expansion of suppressor T cells
in the draining lymph nodes [10], and Siemasko et al. dem-
onstrated the homeostatic role of CD41FoxP31CD251
cells in the ocular surface [26]. Contrastingly, evidence for
the second implication was lacking, due to the unknown
identity of the autoantigens involved in DED.
In this work, we show for the first time that DS (which
typifies challenging environmental conditions) leads to a
generalized disruption of ocular surface immune tolerance
by using a different approach: the introduction of a
known antigen to the ocular surface milieu (Fig. 1a).
Antigen-specific effector T cells were induced in mice
under DS instead of regulatory T cells, which led to full-
blown DTH responses (Fig. 1b). Strikingly, mucosal toler-
ance disruption at the ocular surface was detected only if
antigen administration was delayed for at least 3 days of
DS, irrespective of whether it was continued beyond this
point. This finding supports the pivotal role of antigen-
specific Tregs, which are induced early in the course of DS
from naive T cells, and prevent any further development
of effector T cells (Fig. 2). In other words, at least 3 days
of DS were required to modify the imprint that the ocular
surface exerts on migrating antigen-presenting cells [27],
which may indicate that a threshold of ocular surface
damage must be surpassed in order for mucosal tolerance
Fig. 3. Topical nuclear factor kappa B (NF-jB) inhibition improves desiccating-stress (DS)-induced dry eye. Mice were kept under no
environmental stress (Ct) or exposed to DS with saline instillation DS or with topical NF-jB inhibitor pyrrolidine dithiocarbamate (PDTC)
(DS1inh) for 5 days. (a) Corneal epithelial integrity on day 5 in Ct, DS and DS 1 inh mice, as measured by corneal fluorescein staining.
Representative photographs (left) of pooled data graded as described in Methods (right). (b) Daily tear production measurements in Ct mice
(empty black circles), in DS mice (filled grey circles or bars) and in DS 1 inh mice (empty grey circles or bars). Representative experiment with
absolute measurements (left) and all data (right) pooled and analysed in 5-day time-periods, expressed as relative to Ct mice. (c) Interleukin
(IL)-1b and IL-6 production by eye explants obtained on day 5 from Ct, DS and DS 1 inh mice. Data are expressed as mean 6 standard error
of the mean (s.e.m.) (n 5 3–5 experiments, 3–5 mice/group, BALB/c mice); *n.s. indicates a statistically significant or non-significant difference,
respectively, between the marked groups, as determined by analysis of variance (ANOVA) and Sidak’s post-hoc test.
Mucosal tolerance disruption in dry eye
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to be overcome. In line with this idea, the immune devia-
tion at the ocular surface coincided in time with the early
peak described for IFN-g secretion by conjunctival NK
cells, which favours proinflammatory DC maturation
[28]. DS has been shown to induce early changes in the
ocular surface epithelium that typify a stress response,
which include increased retinoic acid early inducible gene
1 expression [29] and mitogen-activated protein kinase
activation [30]. NF-jB activation is a common down-
stream event in most epithelial stress responses [14], and
increased NF-jB signalling in the corneal and conjunctival
epithelia has been reported in different models of ocular
surface disorders [11,31]. The relevance of epithelial NF-
jB activation lies in the decisive role it plays in the muco-
sal immune outcome [14–16]. Whereas reduced basal NF-
jB activity leads to tolerogenic conditioning of dendritic
cells and induction of Tregs, increased epithelial NF-jB sig-
nalling promotes immunogenic dendritic cell maturation
and effector T cell generation in the lymph nodes
[11,16,32]. Consistently, our finding of DS-induced muco-
sal tolerance disruption is also dependent upon local
NF-jB activation (Fig. 1c).
Fig. 4. Topical nuclear factor kappa B (NF-jB) inhibition prevents the development of a proinflammatory T cell response. Mice were kept under
no environmental stress (Ct) or exposed to desiccating stress (DS) with saline instillation (DS) or with topical NF-jB inhibitor pyrrolidine
dithiocarbamate (PDTC) (DS 1 inh) for 5 days. (a) T cell proliferation in submandibular lymph node cells from Ct (hatched bars), DS (filled
bars) and DS 1 inh (empty bars) mice on day 5, as induced by different anti-CD3 antibody concentrations. Pooled data expressed relative to Ct
mice (left). Representative experiment (right) with overlaid histograms from cultures with 0 (grey filled), 001 (black), 01 (red) and 1 (blue) mg/
ml anti-CD3 antibody, and the corresponding proliferative fraction shown in the same order. (b) Phenotype and cytokine production in CD41 T
cells obtained on day 5 from submandibular lymph nodes of Ct, DS and DS 1 inh mice. (c) Adoptive transfer of CD31 T cells harvested from
Ct, DS and DS 1 inh mice on day 5, labelled with carboxyfluorescein succinimidyl ester (CFSE) and injected into recipients (15 3 106 cells/
mouse) that were subjected to mild desiccating stress (forced airflow without scopolamine) for 3 days. Pooled data (left) and representative dot
plots (right) of cervical lymph node cells as analysed by fluorescence activated cell sorter (FACS). Data are expressed as mean 6 standard error
of the mean (s.e.m.) (n 5 3–5 experiments, 3–5 mice/group, BALB/c mice); n.s. indicates a statistically significant or non-significant difference,
respectively, between the marked groups, as determined by analysis of variance (ANOVA) and Sidak’s post-hoc test.
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The observed skewing of the ocular surface’s immune
response towards an exogenous antigen could be regarded
as an epiphenomenon of the already described and well-
characterized Th1 and Th17 responses against corneal and
conjunctival antigens [5,13]. In other words, epithelial NF-
jB signalling could be a side effect of local NK cell and/or
effector Th1 and Th17 cell activation, relatively independ-
ent of these key pathogenic events in DED onset. However,
topical inhibition of NF-jB activity under DS reduced dis-
ease signs markedly in the murine model, highlighting the
importance of this step in DED progression (Fig. 3). This
assertion is supported further by the observed changes in
the underlying T cell response. Maintenance of mucosal
tolerance at the ocular surface by reducing local NF-jB
activation led to increased regulatory T cell activity and
decreased effector Th1 and Th17 responses (Fig. 4), which
are ultimately responsible for the corneal and conjunctival
damage that typifies DED. Of note, these changes were
observed in the entire T cell compartment of the eye-
draining lymph nodes and were not restricted to OVA-
specific T cells, as there was no antigen instillation in those
experiments. Our findings are consistent with the reported
relevance of NF-jB signalling in immune homeostasis in
other mucosal sites. In asthma, a paradigmatic example of
disrupted mucosal tolerance towards foreign antigens, NF-
jB inhibitors can prevent pathogenic T cell responses [33].
Moreover, inflammatory bowel disease, which is caused by
a dysregulated mucosal immune response towards com-
mensal flora [34], is associated with loss of oral tolerance
to fed antigens [35]. Sulphasalazine and its analogues have
been in clinical use for decades for local treatment of this
disorder [36], and other NF-jB inhibitors can ameliorate
colitis in murine models [37]. Regarding the relevance of
NF-jB pathway in ocular surface homeostasis, targeted dis-
ruption of IjBf (a negative regulator of NF-jB activity) in
mice led to a marked inflammatory phenotype with loss of
goblet cells and CD41 cell infiltration [38]. Also, a knock-
in mouse model of enhanced NF-jB activity resulted in
increased T cell activation and a Sj€ogren syndrome-like
phenotype [39] and, conversely, targeted loss of a NF-jB
regulator led to chronic intestinal mucosal inflammation
[40]. In line with these reports, alternative (anti-inflamma-
tory) NF-jB activation induced by an oligonucleotide
improved Sj€ogren’s syndrome in another murine model
[41]. Finally, it should be mentioned that the DED model
used in this work requires both scopolamine injections and
forced air flow to reproduce a full-blown eye disease. Sys-
temic scopolamine is known to have effects per se on T cells
[42] and endothelial cells [43], so our findings should be
corroborated in other models of DED that do not employ
this anticholinergic [44–46].
In summary, our findings show that DS disrupts the
ocular surface’s immune homeostasis, as evidenced by
mucosal tolerance or lack thereof. Moreover, we also
observed that topical modulation of NF-jB activation leads
to improvement of clinical markers of DED in mice
exposed to DS, suggesting that disruption of the ocular
surface’s immune tolerance is an important pathogenic
event. These findings provide experimental evidence for
the dysregulated autoimmune hypothesis for DED [12]. As
mechanistic insight, we demonstrate that topical NF-jB
inhibitors can prevent the DS-induced skewing in the
mucosal immune response towards a Th1/Th17 phenotype,
and thus block the development of the effector T cell
response that causes DED. Thus, attempts at modulating
mucosal tolerance could have a positive impact on DED.
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